{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:46:20Z","timestamp":1793094380818,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.clgc.2024.102224","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T17:55:05Z","timestamp":1726595705000},"page":"102224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of Neoadjuvant Chemotherapy Utilization, Pathologic Response, and Overall Survival in Upper Tract Urothelial Carcinoma"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4562-4824","authenticated-orcid":false,"given":"Vincent E.","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8716-7457","authenticated-orcid":false,"given":"Oluwafolajimi","family":"Adesanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Azari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4503-0953","authenticated-orcid":false,"given":"Samita","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7147-7119","authenticated-orcid":false,"given":"Matthew","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2240-6875","authenticated-orcid":false,"given":"Arthur","family":"Drouaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0947-407X","authenticated-orcid":false,"given":"Ryan M.","family":"Antar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2851-1609","authenticated-orcid":false,"given":"Phat","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3846-0235","authenticated-orcid":false,"given":"Armine","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2423-072X","authenticated-orcid":false,"given":"Michael J","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clgc.2024.102224_bib0001","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.clgc.2024.102224_bib0002","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.clgc.2024.102224_bib0003","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jso.25877","article-title":"Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract","volume":"121","author":"Rosiello","year":"2020","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2024.102224_bib0004","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.euo.2020.11.005","article-title":"Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma","volume":"4","author":"Coll\u00e0 Ruvolo","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2024.102224_bib0005","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.urolonc.2016.11.018","article-title":"Neoadjuvant and adjuvant chemotherapy use in upper tract urothelial carcinoma","volume":"35","author":"Cohen","year":"2017","journal-title":"Urol Oncol"},{"issue":"7","key":"10.1016\/j.clgc.2024.102224_bib0006","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1200\/JCO.1992.10.7.1066","article-title":"A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study","volume":"10","author":"Loehrer","year":"1992","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.clgc.2024.102224_bib0007","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.23.01659","article-title":"Improved disease-free survival with adjuvant chemotherapy after nephroureterectomy for upper tract urothelial cancer: final results of the POUT Trial","volume":"42","author":"Birtle","year":"2024","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.clgc.2024.102224_bib0008","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.clgc.2024.102224_bib0009","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.eururo.2010.06.029","article-title":"Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy","volume":"58","author":"Kaag","year":"2010","journal-title":"Eur Urol"},{"issue":"10232","key":"10.1016\/j.clgc.2024.102224_bib0010","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.clgc.2024.102224_bib0011","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/cncr.25043","article-title":"Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy","volume":"116","author":"Lane","year":"2010","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2024.102224_bib0012","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/bju.15346","article-title":"Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study","volume":"128","author":"Hamaya","year":"2021","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.clgc.2024.102224_bib0013","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12894-022-01112-6","article-title":"Neoadjuvant versus adjuvant chemotherapy in upper tract urothelial carcinoma: a nationwide cohort study","volume":"22","author":"Tae","year":"2022","journal-title":"BMC Urol"},{"issue":"13","key":"10.1016\/j.clgc.2024.102224_bib0014","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/cncr.25050","article-title":"Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma","volume":"116","author":"Matin","year":"2010","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2024.102224_bib0015","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/JU.0000000000000644","article-title":"Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma","volume":"203","author":"Margulis","year":"2020","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.clgc.2024.102224_bib0016","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1200\/JCO.22.00763","article-title":"Multicenter phase ii clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma","volume":"41","author":"Coleman","year":"2023","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2024.102224_bib0017","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1464-410X.2009.08821.x","article-title":"A delay in radical nephroureterectomy can lead to upstaging","volume":"105","author":"Waldert","year":"2010","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.clgc.2024.102224_bib0018","doi-asserted-by":"crossref","first-page":"10.e15","DOI":"10.1016\/j.urolonc.2017.09.013","article-title":"Impact of surgical waiting time on survival in patients with upper tract urothelial carcinoma: a national cancer database study","volume":"36","author":"Xia","year":"2018","journal-title":"Urol Oncol"},{"issue":"11","key":"10.1016\/j.clgc.2024.102224_bib0019","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ejso.2020.06.024","article-title":"Diagnostic accuracy of ureteroscopic biopsy in predicting stage and grade at final pathology in upper tract urothelial carcinoma: Systematic review and meta-analysis","volume":"46","author":"Subiela","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"18","key":"10.1016\/j.clgc.2024.102224_bib0020","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/BF03262330","article-title":"The health economics of bladder cancer: a comprehensive review of the published literature","volume":"21","author":"Botteman","year":"2003","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.clgc.2024.102224_bib0021","doi-asserted-by":"crossref","first-page":"pkab085","DOI":"10.1093\/jncics\/pkab085","article-title":"Treatment patterns, outcomes, and costs associated with localized upper tract urothelial carcinoma","volume":"5","author":"Fero","year":"2021","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.clgc.2024.102224_bib0022","unstructured":"American College of Surgeons: Standards for Oncology Registry Entry (STORE): revised for 2022. Accessed April 1, 2024. https:\/\/www.facs.org\/media\/j5bp1dn4\/store-2023-final-version-06282023.pdf."},{"key":"10.1016\/j.clgc.2024.102224_bib0023","unstructured":"IBM Corp. Released 2022. IBM SPSS Statistics, Version 29.0. Chicago, IL: IBM Corp."},{"issue":"2","key":"10.1016\/j.clgc.2024.102224_bib0024","doi-asserted-by":"crossref","first-page":"198.e1","DOI":"10.1016\/j.clgc.2021.11.016","volume":"20","author":"Del Giudice","year":"2022","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"10.1016\/j.clgc.2024.102224_bib0025","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","article-title":"A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","volume":"66","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102224_bib0026","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1200\/JCO.2018.36.6_suppl.407","article-title":"Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)","volume":"36","author":"Birtle","year":"2018","journal-title":"JCO"},{"issue":"1","key":"10.1016\/j.clgc.2024.102224_bib0027","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2017.12.054","article-title":"Comparison of pathological stage in patients treated with and without neoadjuvant chemotherapy for high risk upper tract urothelial carcinoma","volume":"200","author":"Liao","year":"2018","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/j.clgc.2024.102224_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.49026","article-title":"Survival outcomes and patterns of care for stage II or III resected gastric cancer by race and ethnicity","volume":"6","author":"Wu","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.clgc.2024.102224_bib0029","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.21037\/jtd.2019.08.63","article-title":"Different treatment efficacies and side effects of cytotoxic chemotherapy","volume":"12","author":"Li","year":"2020","journal-title":"J Thorac Dis"},{"issue":"6","key":"10.1016\/j.clgc.2024.102224_bib0030","doi-asserted-by":"crossref","first-page":"e1237","DOI":"10.1016\/j.clgc.2018.08.003","article-title":"Impact of neoadjuvant chemotherapy on pathologic response in patients with upper tract urothelial carcinoma undergoing extirpative surgery","volume":"16","author":"Almassi","year":"2018","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"10.1016\/j.clgc.2024.102224_bib0031","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.eururo.2009.07.002","article-title":"Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy","volume":"57","author":"Raman","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102224_bib0032","doi-asserted-by":"crossref","first-page":"95.e1","DOI":"10.1016\/j.clgc.2021.10.002","article-title":"Discordance between clinical and pathological staging and grading in upper tract urothelial carcinoma","volume":"20","author":"Mori","year":"2022","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2024.102224_bib0033","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/iju.IJU_142_19","article-title":"Trends in the use of neoadjuvant chemotherapy for bladder cancer with nonurothelial variant histology: An analysis of the National Cancer Database","volume":"35","author":"Grant","year":"2019","journal-title":"Indian J Urol"},{"key":"10.1016\/j.clgc.2024.102224_bib0034","unstructured":"The association between mortality and distance to treatment facility in patients with muscle invasive bladder cancer - PubMed. Accessed June 23, 2024. https:\/\/pubmed.ncbi.nlm.nih.gov\/29030318\/."},{"issue":"6","key":"10.1016\/j.clgc.2024.102224_bib0035","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/JU.0000000000003480","article-title":"Diagnosis and management of non-metastatic upper tract urothelial carcinoma: AUA\/SUO Guideline","volume":"209","author":"Coleman","year":"2023","journal-title":"J Urol"},{"issue":"22","key":"10.1016\/j.clgc.2024.102224_bib0036","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.clgc.2024.102224_bib0037","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1007\/s00345-023-04596-5","article-title":"Design and rationale of a single-arm phase II study of neoadjuvant Durvalumab and Gemcitabine associated with Cisplatin or Carboplatin for upper urinary tract urothelial cancer: the iNDUCT trial (NCT04617756)","volume":"41","author":"Calleris","year":"2023","journal-title":"World J Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324001940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324001940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:31:35Z","timestamp":1762551095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767324001940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1558767324001940"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102224","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of Neoadjuvant Chemotherapy Utilization, Pathologic Response, and Overall Survival in Upper Tract Urothelial Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102224"}}